AI-generated summary
The authors randomized young adults with subthreshold depression to bright light therapy or placebo for eight weeks and examined brain connectivity with fMRI. They report that bright light therapy was associated with reduced depression scores and with connectivity changes involving the amygdala, including links to serotonin receptor distributions. The study is limited by the authors' own framing of these as associations and by the lack of volume change, which they note.
- Who or what was studied
- Young adults with subthreshold depression
- Limits stated in the abstract
- The abstract reports associations between imaging changes and serotonin receptor maps and does not establish causal mechanisms or clinical significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Functional magnetic resonance imaging, Bright light therapy, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.